Zobrazeno 1 - 10
of 768
pro vyhledávání: '"Jean-louis Montastruc"'
Publikováno v:
Pharmacy, Vol 8, Iss 1, p 39 (2020)
Introduction: As of 2019, people older than 65 years represent 20% of the French population. Despite several guidelines suggesting to avoid potentially inappropriate medication (PIM) use in elderly, the prevalence of their prescription remains high (
Externí odkaz:
https://doaj.org/article/c5ef55547cff4ab68284605f5b05bd03
Autor:
François Montastruc, Guillaume Moulis, Aurore Palmaro, Virginie Gardette, Geneviève Durrieu, Jean-Louis Montastruc
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e104828 (2014)
BackgroundThe present study aimed to describe exposure and attitudes of French medical residents towards pharmaceutical industry. The study was performed shortly after the Mediator affair which revealed several serious conflicts of interest inside th
Externí odkaz:
https://doaj.org/article/43cfcdc01bbb49328d523ba890d0282b
Autor:
Guillaume Moulis, Agnès Sommet, Johana Béné, François Montastruc, Laurent Sailler, Jean-Louis Montastruc, Maryse Lapeyre-Mestre
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e48991 (2012)
BACKGROUND: The risk of malignancies on TNF-α antagonists is controversial. The aim of this survey was to assess cancer risk on TNF-α antagonists in adult rheumatoid arthritis patients, including the five marketed drugs (infliximab, etanercept, ada
Externí odkaz:
https://doaj.org/article/a819b1993a034f72addb7f0e688ae46d
Autor:
Jean-Pascal Fournier, Maryse Lapeyre-Mestre, Agnès Sommet, Julie Dupouy, Jean-Christophe Poutrain, Jean-Louis Montastruc
Publikováno v:
PLoS ONE, Vol 7, Iss 3, p e34187 (2012)
BACKGROUND: Drug-Drug Interactions between Non Steroidal Anti-Inflammatory Drugs (NSAIDs) and Angiotensin Converting Enzyme Inhibitors (ACEIs), Angiotensin Receptor Blocker (ARBs) or diuretics can lead to renal failure and hyperkalemia. Thus, monitor
Externí odkaz:
https://doaj.org/article/7efd46af7e38422eae4b88db4a180222
Autor:
Jean‐Louis Montastruc
Publikováno v:
British Journal of Clinical Pharmacology.
Publikováno v:
British Journal of Clinical Pharmacology.
Autor:
Farzin Khosrow‐Khavar, Laurent Azoulay, Jean‐Louis Montastruc, François Montastruc, Christel Renoux
Publikováno v:
Cancer. 128:2339-2347
Current guidelines recommend the treatment of hormone receptor-positive breast cancer with aromatase inhibitors (AIs) and tamoxifen in the adjuvant setting. Some observational studies have raised concerns that tamoxifen may be associated with an incr
Publikováno v:
Fundamental & Clinical Pharmacology. 36:443-447
Diarrhea is an adverse drug reaction (ADR) widely reported with olmesartan, an angiotensin II receptor blocker (ARB). Isolated case reports described this ADR with other ARBs. The present study was performed to investigate if, among the different ARB
Publikováno v:
European Journal of Clinical Pharmacology. 79:701-702
Autor:
Jean-Louis Montastruc
Publikováno v:
European Journal of Clinical Pharmacology. 79:569-570